Page last updated: 2024-11-04

sb 220025 and Asthma

sb 220025 has been researched along with Asthma in 1 studies

SB 220025: inhibits p38 mitogen-activated protein kinase; structure in first source
SB220025 : Am member of the class of imidazoles carrying piperidin-4-yl, 4-fluophenyl and 2-aminopyrimidin-4-yl substituents at posiitons 1, 4 and 5 respectively.

Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Seow, CJ1
Chue, SC1
Duan, W1
Yeo, KS1
Koh, AH1
Wong, WS1

Other Studies

1 other study available for sb 220025 and Asthma

ArticleYear
Effects of inhibitors of the tyrosine signalling cascade on antigen challenge of guinea pig airways in vitro.
    Annals of the Academy of Medicine, Singapore, 2004, Volume: 33, Issue:5 Suppl

    Topics: Animals; Asthma; Butadienes; Calcium-Calmodulin-Dependent Protein Kinases; Enzyme Inhibitors; Guinea

2004